Author: John Cumbers and Karl Schmieder

Eleonore Pauwels on the Intersection of Genomics, Synthetic Biology, Artificial Intelligence, and Security

As part of our new book “What’s Your Bio Strategy?” we’ve interviewed dozens of entrepreneurs, business leaders and academics working on synthetic biology. The following is an excerpt from one of those interviews. To find out when the book goes on sale subscribe to our newsletter here. Eleonore Pauwels is the director of Science Innovation with the Science and Technology Innovation Program at the Wilson Center in Washington, D.C. She studies the intersection of genomics, synthetic biology, artificial intelligence, and intellectual property. As biological technologies become digitized, they will face the same security issues as information technologies. KARL SCHMIEDER:...

Read More

Eben Bayer: Chickens Are More Complicated than iPhones

As part of our new book “What’s Your Bio Strategy?” we’ve interviewed dozens of entrepreneurs, business leaders and academics working on synthetic biology. The following is an excerpt from one of those interviews. To find out when the book goes on sale subscribe to our newsletter here. Eben Bayer, co-Founder and CEO of Ecovative, is a leader in the biomaterial industry. He is a co-inventor of MycoBond, strong, natural building composites created by growing organism that turn low-value agricultural waste products into strong, natural composites. With Ecovative, he is leading efforts to create sustainable and affordable products. JOHN CUMBERS: What is Ecovative’s origin story? EBEN BAYER: It...

Read More

Andras Forgacs: Design And Biofabrication Is Revolutionizing Materials

As part of our new book “What’s Your Bio Strategy?” we’ve interviewed dozens of entrepreneurs, business leaders and academics working on synthetic biology. The following is an excerpt from one of those interviews. To find out when the book goes on sale subscribe to our newsletter here.   When you look at the synthetic biology community, there are companies manufacturing genes, developing computational tools, and creating cloud labs and automation tools. Others are engineering organisms and developing applications using living materials. The definition includes companies that use biology to fabricate things – biofabrication companies. Brooklyn-based Modern Meadow grew out of the ground-breaking tissue and organ printing company,...

Read More

Darlene Solomon: Biotech Already Touches Your Life Every Day

As part of our new book “What’s Your Bio Strategy?” we’ve interviewed dozens of entrepreneurs, business leaders and academics working on synthetic biology. The following is an excerpt from one of those interviews. To find out when the book goes on sale subscribe to our newsletter here. A core part of biotechnology is measurement – the ability to measure the changes you’ve made to a genome, to a microorganisms. Agilent is a company founded on the technology and ability to measure the world around us. Any book on SynBio should include a discussion on measurement, so we interviewed Agilent’s Chief Technology Officer, Darlene Solomon.  Darlene leads Agilent with...

Read More

Ginkgo Bioworks CEO Jason Kelly: We’re Building the Microbe Design Industry

As part of our new book “What’s Your Bio Strategy?” we’ve interviewed dozens of entrepreneurs, business leaders and academics working on synthetic biology. The following is an excerpt from one of those interviews. To find out when the book goes on sale subscribe to our newsletter here. In 2008, Jason Kelly with a group of peers from MIT co-founded Ginkgo BioWorks. The Boston-based company focuses on designing and developing organisms for use across industries and has developed an integrated technology platform that includes hardware, software, and wetware. Ginkgo BioWorks was the first biotechnology company to be admitted to Y-Combinator’s world-famous start-up incubator. An outspoken supporter of genetic...

Read More